News for February, 2009

Girl suffers SJS after receiving tetanus shot

A 7-year-old girl who received a tetanus shot along with several other children at school is now in Sentra Medika Hospital in Cimanggis, Depok, receiving treatment for Stevens Johnson Syndrome (SJS), according to The Jakarta Globe.

Read the rest of this entry »

Study focuses on eye complications from SJS/TEN

chart eye exam 150x150A group of researchers has found that patients with Stevens Johnson Syndrome (SJS) or toxic epidermal necrolysis (TEN) who have ocular complications are more likely to have late complications with their eyes and thus should undergo ophthalmologic screening, according to the February 2009 edition of the Archives of Dermatology. The cohort study focused on the acute and late ocular manifestations of and its more severe form, TEN, and how to identify predictors for the development of ocular complications.

Read the rest of this entry »

SJS damaged Vietnamese man’s eyes, but he hopes to see again

blind 044 09 150x150It seems Ngo Quang Thi has been fighting all his life. As a third-grader, he received an injection to help him overcome a fever, but the injection drove him into a coma. He became violently ill, developing a rash over his body. His skin began to peel off and blisters formed in his mouth, nose and eyes. He was later diagnosed with Stevens Johnson Syndrome (SJS), a rare but life threatening allergic reaction to medication. Because of the scarring on his eyes, he began to lose vision immediately.

Read the rest of this entry »

SAEC releases first data on serious adverse events caused by drugs

pharmacogenetics 150x150The International Serious Adverse Event Consortium (SAEC) this week released its first data, offering health care professionals more insight into the genetic basis for two serious adverse drug events – Stevens Johnson Syndrome (SJS) and its most severe form, toxic epidermal necrolysis (TEN), according to Health News Digest.

Read the rest of this entry »

HIV treatment linked to slight risk of SJS/TEN

intelence bottle lr1 109x150Drug maker Tibotec, which specializes in innovative therapeutic and diagnostic solutions for infectious diseases such as HIV/AIDS, is seeking approval from the FDA for its latest HIV treatment, Intelence, based on data from its phase-three studies of the drug when used in combination with other antiretroviral agents, according to a press release from Hays Pharma, a global pharmaceutical and biotech staffing and recruitment business.

Read the rest of this entry »

High school wrestler’s fight against SJS heroic

At a mere 139 pounds, Ryan Mead was a far cry from his 167-pound fighting weight. The Marysville-Pilchuck, Washington, high school senior is the captain of his wresting team. The fact that he showed up for the Class 4A District 1 Wresting Tournament in the first place was heroic, according to the Herald Net. Ryan had just recovered from a serious, life-threatening condition known as Stevens Johnson Syndrome, or SJS.

Read the rest of this entry »

TAMIFLU carries risk of serious adverse reaction

Winter is the prime time for the flu. The Centers for Disease Control and Prevention recommends a yearly flu vaccine as the first and most important step in protecting against this serious disease. For those who don’t get the vaccine – and for some who do – influenza can occur.

Read the rest of this entry »

Ethyol now linked to SJS, TEN

A prescription drug given to counter a side effect of radiation for head and neck cancer now carries a warning about possible serious adverse reactions to the medication known as Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). Ethyol (amifostine) was among 29 drugs listed in a Jan. 30th FDA MedWatch announcement of drug products with safety labeling changes to their boxed warnings, contraindications, warnings, precautions, adverse reactions, patient package inserts and medication guides.

Read the rest of this entry »